ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

YULC Yule Catto

178.90
0.00 (0.00%)
06 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Yule Catto LSE:YULC London Ordinary Share GB0009887422 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 178.90 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Pre-Close Update

11/12/2003 7:00am

UK Regulatory


RNS Number:1132T
Yule Catto & Co PLC
11 December 2003


                            YULE CATTO & COMPANY PLC
                                        
                                Pre-Close Update

In keeping with market practice, Yule Catto & Company plc is today issuing its
pre-close trading statement for the financial year to 31 December 2003, prior to
the company's preliminary results announcement, scheduled for Thursday March 4
2004.

The company confirms that trading in the second half of 2003 has seen reasonable
volumes across all business sectors and that results should meet expectations.

However, in line with the chemical industry in general, the persistently high
price of oil is continuing to make it difficult to predict raw material prices
for 2004 and the current weakness of the US dollar is a further challenge.
Following the launch of competitive generic products, the outlook for
omeprazole, one of our main generic pharmaceutical actives, in the USA also
remains somewhat unclear.

The strategy of growing our water-based polymers is bearing fruit, with pleasing
volumes being sold from our new Malaysian and Belgian facilities. The generic
and ethical product development programme for our Pharma business continues to
widen and deepen with the benefits likely to emerge from 2005 onwards. To
improve performance, initiatives to restructure some of the performance chemical
businesses and bring new innovative products to market are ongoing.

We remain confident that the present business strategy will deliver good growth
over the medium and long term for Yule Catto.

                                                                11 December 2003

ENQUIRIES:

YULE CATTO                                                    Tel: 01279 442791
Alex Walker, Chief Executive
Sean Cummins, Finance Director

COLLEGE HILL                                                  Tel: 020 7457 2020
Gareth David                                 email: gareth.david@collegehill.com
Crawford Burden                            email:crawford.burden@collegehill.com
                                           -------------------------------------


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
TSTNKKKQABDDDBD

1 Year Yule Catto Chart

1 Year Yule Catto Chart

1 Month Yule Catto Chart

1 Month Yule Catto Chart

Your Recent History

Delayed Upgrade Clock